The use of lidocaine containing cardioplegia in surgery for adult acquired heart disease

Journal of Cardiac Surgery

Volumn 30, Issue 9, 2015, Pages 677-684

  Yammine, Maroun ^a   Neely, Robert C ^a   Loberman, Dan ^a   Rajab, Taufiek Konrad ^a   Grewal, Amardeep ^a   McGurk, Siobhan ^a   Fitzgerald, Daniel ^a   Aranki, Sary F ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CREATINE KINASE MB; LIDOCAINE; POTASSIUM CARDIOPLEGIC SOLUTION; POTASSIUM DERIVATIVE;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; CARDIOPLEGIA; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HEART DISEASE; HEART SURGERY; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PROPENSITY SCORE; RETROSPECTIVE STUDY; SINGLE DRUG DOSE; VERY ELDERLY; COMPARATIVE STUDY; HEART ARREST; HEART DISEASES; MIDDLE AGED; OPERATION DURATION; PROCEDURES; SURGICAL EQUIPMENT; TIME FACTOR; TREATMENT OUTCOME;

AGED; CARDIAC SURGICAL PROCEDURES; CREATINE KINASE, MB FORM; FEMALE; HEART ARREST, INDUCED; HEART DISEASES; HUMANS; LENGTH OF STAY; LIDOCAINE; MALE; MIDDLE AGED; OPERATIVE TIME; POTASSIUM COMPOUNDS; PROPENSITY SCORE; RETROSPECTIVE STUDIES; SURGICAL INSTRUMENTS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84940788625     PISSN: 08860440     EISSN: 15408191     Source Type: Journal    
DOI: 10.1111/jocs.12597     Document Type: Article

References (32)

1. Toyoda Y, Yamaguchi M, Yoshimura N, et al,: Cardioprotective effects and the mechanisms of terminal warm blood cardioplegia in pediatric cardiac surgery. J Thorac Cardiovasc Surg 2003; 125 (6): 1242-1251.
2. Matte GS, del Nido PJ., History and use of del Nido cardioplegia solution at Boston Children's Hospital. J Extra Corpor Technol 2012; 44 (3): 98-103.
3. Larach DR, Solina AR,: Cardiovascular drugs. In, Hensley FA, Martin DE, (eds): A practical approach to cardiac anesthesia. 2nd ed. Little, Brown and Company, Boston, pp. 32-95.
4. O'Blenes SB, Friesen CH, Ali A, et al,: Protecting the aged heart during cardiac surgery: The potential benefits of del Nido cardioplegia. J Thorac Cardiovasc Surg 2011; 141 (3): 762-770.
5. Sorabella RA, Akashi H, Yerebakan H, et al,: Myocardial protection using del Nido cardioplegia solution in adult reoperative aortic valve surgery. J Card Surg 2014; 29 (4): 445-449.
6. Yerebakan H, Sorabella RA, Najjar M, et al,: Del Nido cardioplegia can be safely administered in high-risk coronary artery bypass grafting surgery after acute myocardial infarction: A propensity matched comparison. J Cardiothorac Surg 2014; 9 (1): 141.
7. Charette K, Gerrah R, Quaegebeur J, et al,: Single dose myocardial protection technique utilizing del Nido cardioplegia solution during congenital heart surgery procedures. Perfusion 2012; 27 (2): 98-103.
8. Julia PL, Buckberg GD, Acar C, et al,: Studies of controlled reperfusion after ischemia. XXI. Reperfusate composition: Superiority of blood cardioplegia over crystalloid cardioplegia in limiting reperfusion damage-importance of endogenous oxygen free radical scavengers in red blood cells. J Thorac Cardiovasc Surg 1991; 101 (2): 303-313.
9. McCann UG, 2nd, Lutz CJ, Picone AL, et al,: Whole blood cardioplegia (minicardioplegia) reduces myocardial edema after ischemic injury and cardiopulmonary bypass. J Extra Corpor Technol 2006; 38 (1): 14-21.
10. Iseri LT, French JH, Magnesium: Nature's physiologic calcium blocker. Am Heart J 1984; 108 (1): 188-193.
11. Shakerinia T, Ali IM, Sullivan JA., Magnesium in cardioplegia: Is it necessary? Can J Surg 1996; 39 (5): 397-400.
12. Guyton RA,. The myocardium: Physiology and protection during cardiac surgery and cardiopulmonary bypass. Springer-Verlag, New York, 1995.
13. O'Brien JD, Howlett SE, Burton HJ, et al,: Pediatric cardioplegia strategy results in enhanced calcium metabolism and lower serum troponin T. Ann Thorac Surg 2009; 87 (5): 1517-1523.
14. Govindapillai A, Hua R, Rose R, et al,: Protecting the aged heart during cardiac surgery: Use of del Nido cardioplegia provides superior functional recovery in isolated hearts. J Thorac Cardiovasc Surg 2013; 146 (4): 940-948.
15. Dobson GP, Jones MW., Adenosine and lidocaine: A new concept in nondepolarizing surgical myocardial arrest, protection, and preservation. J Thorac Cardiovasc Surg 2004; 127 (3): 794-805.
16. Chambers DJ., Polarization and myocardial protection. Curr Opin Cardiol 1999; 14 (6): 495-500.
17. Ataka K, Chen D, Levitsky S, et al,: Effect of aging on intracellular Ca2+, pHi, and contractility during ischemia and reperfusion. Circulation 1992; 86 (5 Suppl): Ii371-Ii376.
18. Tsukube T, McCully JD, Metz KR, et al,: Amelioration of ischemic calcium overload correlates with high-energy phosphates in senescent myocardium. Am J Physiol 1997; 273: H418-H425.
19. O'Brien JD, Ferguson JH, Howlett SE., Effects of ischemia and reperfusion on isolated ventricular myocytes from young adult and aged Fischer 344 rat hearts. Am J Physiol Heart Circ Physiol 2008; 294 (5): H2174-H2183.
20. Steenbergen C, Murphy E, Watts JA, et al,: Correlation between cytosolic free calcium, contracture, ATP, and irreversible ischemic injury in perfused rat heart. Circ Res 1990; 66 (1): 135-146.
21. Piper HM, Garcia-Dorado D., Prime causes of rapid cardiomyocyte death during reperfusion. Ann Thorac Surg 1999; 68 (5): 1913-1919.
22. ten Hove M, Jansen MA, Nederhoff MG, et al,: Combined blockade of the Na+ channel and the Na+/H+ exchanger virtually prevents ischemic Na+ overload in rat hearts. Mol Cell Biochem 2007; 297 (1-2): 101-110.
23. Lee JA, Allen DG., Mechanisms of acute ischemic contractile failure of the heart. Role of intracellular calcium. J Clin Invest 1991; 88 (2): 361-367.
24. Hondeghem LM, Katzung BG., Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels. Biochim Biophys Acta 1977; 472 (3-4): 373-398.
25. Hall SK, Fry CH., Magnesium affects excitation, conduction, and contraction of isolated mammalian cardiac muscle. Am J Physiol 1992; 263 (2 Pt 2): H622-H633.
26. Kotani Y, Tweddell J, Gruber P, et al,: Current cardioplegia practice in pediatric cardiac surgery: A North American multiinstitutional survey. Ann Thorac Surg 2013; 96 (3): 923-929.
27. Domanski MJ, Mahaffey K, Hasselblad V, et al,: Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery. JAMA 2011; 305 (6): 585-591.
28. Soraas CL, Friis C, Engebretsen KV, et al,: Troponin T is a better predictor than creatine kinase-MB of long-term mortality after coronary artery bypass graft surgery. Am Heart J 2012; 164 (5): 779-785.
29. Petaja L, Salmenpera M, Pulkki K, et al,: Biochemical injury markers and mortality after coronary artery bypass grafting: A systematic review. Ann Thorac Surg 2009; 87 (6): 1981-1992.
30. Mastro F, Guida P, Scrascia G, et al,: Cardiac troponin I and creatine kinase-MB release after different cardiac surgeries. J Cardiovasc Med (Hagerstown) 2014; 16 (6): 456-464.
31. Singh S, Kapoor A, Agarwal SK, et al,: Differential release kinetics of cardiac biomarkers in patients undergoing valve replacement surgery. J Card Surg 2014; 29 (2): 134-140.
32. Ramsay J, Shernan S, Fitch J, et al,: Increased creatine kinase MB level predicts postoperative mortality after cardiac surgery independent of new Q waves. J Thorac Cardiovasc Surg 2005; 129 (2): 300-306.